An update on the NLRP3 inflammasome and influenza: the road to redemption or perdition?

Current Opinion in Immunology

Volumn 54, Issue , 2018, Pages 80-85

  Michelle D, Tate ^b   Ashley, Mansell ^b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; RNA;

HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; INFLUENZA A; INFLUENZA A VIRUS; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PROTEIN TARGETING; PYROPTOSIS; REVIEW; VIRUS ACTIVATION; VIRUS INFECTION; VIRUS INHIBITION; ANIMAL; IMMUNOLOGY;

ANIMALS; HUMANS; INFLAMMASOMES; INFLAMMATION; INFLUENZA A VIRUS; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN;

EID: 85049318091     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2018.06.005     Document Type: Review

References (48)

1. Wu, Z.Q., Zhang, Y., Zhao, N., Yu, Z., Pan, H., Chan, T.C., Zhang, Z.R., Liu, S.L., Comparative epidemiology of human fatal infections with novel, high (H5N6 and H5N1) and low (H7N9 and H9N2) pathogenicity avian influenza A viruses. Int J Environ Res Public Health, 14, 2017.
2. Lam, T.T., Zhou, B., Wang, J., Chai, Y., Shen, Y., Chen, X., Ma, C., Hong, W., Chen, Y., Zhang, Y., et al. Dissemination, divergence and establishment of H7N9 influenza viruses in China. Nature 522 (2015), 102–105.
3. Johnson, N.P., Mueller, J., Updating the accounts: global mortality of the 1918–1920 ``Spanish" influenza pandemic. Bull Hist Med 76 (2002), 105–115.
4. Herold, S., Becker, C., Ridge, K.M., Budinger, G.R., Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J 45 (2015), 1463–1478.
5. Short, K.R., Kroeze, E., Fouchier, R.A.M., Kuiken, T., Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis 14 (2014), 57–69.
6. Wang, Z., Zhang, A., Wan, Y., Liu, X., Qiu, C., Xi, X., Ren, Y., Wang, J., Dong, Y., Bao, M., et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A 111 (2014), 769–774 This genetic study of H7N9 clinical isolates identifies the rapid diversification of H7N9 avian IAV and that H7N9 may have become enzootic in China. As such, this paper identifies H797 as having the potential to spread beyond the region and become a pandemic strain amongst humans.
7. Yu, L., Wang, Z., Chen, Y., Ding, W., Jia, H., Chan, J.F., To, K.K., Chen, H., Yang, Y., Liang, W., et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis 57 (2013), 1449–1457 One of three contemporaneous studies examining the cytokine and chemokine inflammatory profile of H7N9-infected patients, identifying biomarkers such as IL-1β and IL-18 as poor prognostic markers of disease outcomes.
8. Guo, J., Huang, F., Liu, J., Chen, Y., Wang, W., Cao, B., Zou, Z., Liu, S., Pan, J., Bao, C., et al. The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes. Sci Rep, 5, 2015, 10942 One of three contemporaneous studies examining the cytokine and chemokine inflammatory profile of H7N9-infected patients, identifying biomarkers such as IL-1β and IL-18 as poor prognostic markers of disease outcomes.
9. Ong, J.D., Mansell, A., Tate, M.D., Hero turned villain: NLRP3 inflammasome-induced inflammation during influenza A virus infection. J Leukoc Biol 101 (2016), 863–874.
10. Prochnicki, T., Mangan, M.S., Latz, E., Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation. F1000Res, 2016, 5.
11. Place, D.E., Kanneganti, T.D., Recent advances in inflammasome biology. Curr Opin Immunol 50 (2018), 32–38.
12. Allen, I.C., Scull, M.A., Moore, C.B., Holl, E.K., McElvania-TeKippe, E., Taxman, D.J., Guthrie, E.H., Pickles, R.J., Ting, J.P., The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30 (2009), 556–565 This paper, back-to-back, with Thomaset al. demonstrated the protective role of the inflammasome complex during IAV infection and that deficiency in NLRP3, ASC or Caspase-1 rendered mice hypersusceptible to IAV infection. This study also identified a critical role of the inflammasome in the healing process following infection.
13. Bauer, R.N., Brighton, L.E., Mueller, L., Xiang, Z., Rager, J.E., Fry, R.C., Peden, D.B., Jaspers, I., Influenza enhances caspase-1 in bronchial epithelial cells from asthmatic volunteers and is associated with pathogenesis. J Allergy Clin Immunol 130 (2012), 958–967 e914.
14. Ichinohe, T., Lee, H.K., Ogura, Y., Flavell, R., Iwasaki, A., Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206 (2009), 79–87 Contemporary study to those of Allenet al. and Thomas et al., which identifies the critical role of the NRLP3 inflammasome in mediating the antiviral response to IAV infection. This study also identified viral RNA as an inflammasome agonist and the requirement of the inflammasome for maturation of anti-IAV adaptive immunity.
15. Pothlichet, J., Meunier, I., Davis, B.K., Ting, J.P., Skamene, E., von Messling, V., Vidal, S.M., Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells. PLoS Pathog, 9, 2013, e1003256.
16. Pirhonen, J., Sareneva, T., Julkunen, I., Matikainen, S., Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation. Eur J Immunol 31 (2001), 726–733.
17. Pirhonen, J., Sareneva, T., Kurimoto, M., Julkunen, I., Matikainen, S., Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol 162 (1999), 7322–7329.
18. Thomas, P.G., Dash, P., Aldridge, J.R. Jr, Ellebedy, A.H., Reynolds, C., Funk, A.J., Martin, W.J., Lamkanfi, M., Webby, R.J., Boyd, K.L., et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30 (2009), 566–575 This paper, back-to-back with Allenet al. demonstrated the protective role of the inflammasome complex during IAV infection and that deficiency in NLRP3, ASC or Caspase-1 rendered mice hypersusceptible to IAV infection. This study also identified the sensing of viral RNA by the inflammasome as mechanistically responsible for inducing inflammation.
19. Zhang, H., Luo, J., Alcorn, J.F., Chen, K., Fan, S., Pilewski, J., Liu, A., Chen, W., Kolls, J.K., Wang, J., AIM2 inflammasome is critical for influenza-induced lung injury and mortality. J Immunol 198 (2017), 4383–4393.
20. Ichinohe, T., Pang, I.K., Iwasaki, A., Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol 11 (2010), 404–410 This study identified the critical IAV product, M2, essential for viral replication and fitness, as an agonist of the NLRP3 inflammasome, identifying a pathogen-associated molecular pattern common to seasonal IAV strains.
21. Fernandez, M.V., Miller, E., Krammer, F., Gopal, R., Greenbaum, B.D., Bhardwaj, N., Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells. J Leukoc Biol 99 (2016), 723–734.
22. McAuley, J.L., Tate, M.D., MacKenzie-Kludas, C.J., Pinar, A., Zeng, W., Stutz, A., Latz, E., Brown, L.E., Mansell, A., Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog, 9, 2013, e1003392 The first identification that aggregated viral proteins activate the NLRP3 inflamamsome, similar to endogenous fibrillar proteins such as Aβ peptide and IAPP. This study identified PB1-F2 as a potential major contributor to the hyperinflammation associated with pandemic and lethal IAV infections.
23. Pinar, A., Dowling, J.K., Bitto, N.J., Robertson, A.A., Latz, E., Stewart, C.R., Drummond, G.R., Cooper, M.A., McAuley, J.L., Tate, M.D., et al. PB1-F2 peptide derived from avian influenza A virus H7N9 induces inflammation via activation of the NLRP3 inflammasome. J Biol Chem 292 (2017), 826–836.
24. Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Forster, I., Farlik, M., Decker, T., Du Pasquier, R.A., Romero, P., et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34 (2011), 213–223 Contemporary study to that of Masterset al. that identifies IFN as a major regulatory mechanism of inflammasome priming and function.
25. Masters, S.L., Mielke, L.A., Cornish, A.L., Sutton, C.E., O'Donnell, J., Cengia, L.H., Roberts, A.W., Wicks, I.P., Mills, K.H., Croker, B.A., Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production. EMBO Rep 11 (2010), 640–646 Contemporary study to Guardaet al. and identifies IFN as a major regulatory mechanism of inflammasome priming and function.
26. Kesavardhana, S., Kuriakose, T., Guy, C.S., Samir, P., Malireddi, R.K.S., Mishra, A., Kanneganti, T.D., ZBP1/DAI ubiquitination and sensing of influenza vRNPs activate programmed cell death. J Exp Med 214 (2017), 2217–2229 This study identifies that the sensing of IAV RNA by RIG-I initiates ZBP1-mediated cell death via the RIG-I-MAVS-IFN-β signaling axis. This study brings together earlier studies by Allenet al. and Ichonohe et al. regarding inflammasome recognition of IAV RNA, inflammation and cell death.
27. Kuriakose, T., Kanneganti, T.D., Regulation and functions of NLRP3 inflammasome during influenza virus infection. Mol Immunol 86 (2017), 56–64.
28. Kuriakose, T., Man, S.M., Malireddi, R.K., Karki, R., Kesavardhana, S., Place, D.E., Neale, G., Vogel, P., Kanneganti, T.D., ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol, 1, 2016.
29. Kuriakose, T., Zheng, M., Neale, G., Kanneganti, T.D., IRF1 is a transcriptional regulator of ZBP1 promoting NLRP3 inflammasome activation and cell death during influenza virus infection. J Immunol 200 (2018), 1489–1495 This study identifies IRF1 as a key upstream regulator of inflammasome and cell death during IAV infection, with IRF-deficient cells demonstrating reduced inflammation and cell death.
30. Mills, E.L., Kelly, B., O'Neill, L.A.J., Mitochondria are the powerhouses of immunity. Nat Immunol 18 (2017), 488–498.
31. O'Neill, L.A., Kishton, R.J., Rathmell, J., A guide to immunometabolism for immunologists. Nat Rev Immunol 16 (2016), 553–565.
32. Tannahill, G.M., Curtis, A.M., Adamik, J., Palsson-Mcdermott, E.M., McGettrick, A.F., Goel, G., Frezza, C., Bernard, N.J., Kelly, B., Foley, N.H., et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496 (2013), 238–242.
33. Tannahill, G.M., O'Neill, L.A.J., The emerging role of metabolic regulation in the functioning of Toll-like receptors and the NOD-like receptor Nlrp3. FEBS Lett 585 (2011), 1568–1572.
34. Smallwood, H.S., Duan, S., Morfouace, M., Rezinciuc, S., Shulkin, B.L., Shelat, A., Zink, E.E., Milasta, S., Bajracharya, R., Oluwaseum, A.J., et al. Targeting metabolic reprogramming by influenza infection for therapeutic intervention. Cell Rep 19 (2017), 1640–1653 This study defines the metabolic response in IAV-infected humans and primary respiratory cells, identifying a potential protective therapy by targeting metabolic mitochondrial reprogramming. The implications of this study may be that reducing metabolic function reduces priming (i.e. signal 1) of inflammasome function.
35. Tate, M.D., Ong, J.D., Dowling, J.K., McAuley, J.L., Robertson, A.B., Latz, E., Drummond, G.R., Cooper, M.A., Hertzog, P.J., Mansell, A., Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition. Sci Rep, 6, 2016, 27912 The first study to identify the therapeutic potential of targeting the NLRP3 inflammasome during severe and lethal IAV infection. It also demonstrated the temporal role of the NLRP3 inflammasome, mediating both protective and detrimental inflammation during the time course of IAV pathogenesis.
36. Coates, B.M., Staricha, K.L., Ravindran, N., Koch, C.M., Cheng, Y., Davis, J.M., Shumaker, D.K., Ridge, K.M., Inhibition of the NOD-like receptor protein 3 inflammasome is protective in juvenile influenza a virus infection. Front Immunol, 8, 2017, 782.
37. Coates, B.M., Staricha, K.L., Koch, C.M., Cheng, Y., Shumaker, D.K., Budinger, G.R.S., Perlman, H., Misharin, A.V., Ridge, K.M., Inflammatory monocytes drive influenza A virus-mediated lung injury in juvenile mice. J Immunol 200 (2018), 2391–2404.
38. Ren, R., Wu, S., Cai, J., Yang, Y., Ren, X., Feng, Y., Chen, L., Qin, B., Xu, C., Yang, H., et al. The H7N9 influenza A virus infection results in lethal inflammation in the mammalian host via the NLRP3-caspase-1 inflammasome. Sci Rep, 7, 2017, 7625 This study, for the first time, demonstrated thein vivo effect of inflammasome activation in response to pathogenic H7N9 infection and highlights the importance of the NLRP3 inflammasome protecting against a pandemic strain of IAV.
39. Robinson, K.M., Ramanan, K., Clay, M.E., McHugh, K.J., Pilewski, M.J., Nickolich, K.L., Corey, C., Shiva, S., Wang, J., Alcorn, J.F., The inflammasome potentiates influenza/Staphylococcus aureus superinfection in mice. JCI Insight, 2018, 3.
40. Iwasaki, A., Pillai, P.S., Innate immunity to influenza virus infection. Nat Rev Immunol 14 (2014), 315–328.
41. Pang, I.K., Iwasaki, A., Inflammasomes as mediators of immunity against influenza virus. Trends Immunol 32 (2011), 34–41.
42. Shirey, K.A., Lai, W., Patel, M.C., Pletneva, L.M., Pang, C., Kurt-Jones, E., Lipsky, M., Roger, T., Calandra, T., Tracey, K.J., et al. Novel strategies for targeting innate immune responses to influenza. Mucosal Immunol 9 (2016), 1173–1182 This study demonstrates that targeting TLR4 signaling may be a way of reducing inflammation to protect against lethal IAV infection. The study also identifies a temporal role for TLR4 function and complements the findings of Tateet al. on inflammasome activation.
43. Shirey, K.A., Lai, W., Scott, A.J., Lipsky, M., Mistry, P., Pletneva, L.M., Karp, C.L., McAlees, J., Gioannini, T.L., Weiss, J., et al. The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497 (2013), 498–502 The first study identifying a critical role for TLR4 in IAV infectionin vivo. The use of the TLR4 agonist, Eritoran, represents a novel therapeutic approach for influenza-induced inflammation.
44. Zanoni, I., Tan, Y., Di Gioia, M., Broggi, A., Ruan, J., Shi, J., Donado, C.A., Shao, F., Wu, H., Springstead, J.R., et al. An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells. Science 352 (2016), 1232–1236.
45. Chu, L.H., Indramohan, M., Ratsimandresy, R.A., Gangopadhyay, A., Morris, E.P., Monack, D.M., Dorfleutner, A., Stehlik, C., The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages. Nat Commun, 9, 2018, 996.
46. Savio, L.E.B., de Andrade Mello, P., da Silva, C.G., Coutinho-Silva, R., The P2X7 receptor in inflammatory diseases: angel or demon?. Front Pharmacol, 9, 2018, 52.
47. Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W.P., Weinrauch, Y., Monack, D.M., Dixit, V.M., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440 (2006), 228–232.
48. Leyva-Grado, V.H., Ermler, M.E., Schotsaert, M., Gonzalez, M.G., Gillespie, V., Lim, J.K., Garcia-Sastre, A., Contribution of the purinergic receptor P2X7 to development of lung immunopathology during influenza virus infection. MBio, 8, 2017 This study used chemical inhibition and P2X7r-deficient mice to demonstrate the crucial role of the P2X7 receptor in the induction and exacerbation of pulmonary inflammation and its contribution to IAV pathogenesis.